| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/29/2005 | CN1631434A Oral liquor for treating rheumatism and its preparing method |
| 06/29/2005 | CN1631412A Medicinal extractive with favorable inflammation eliminating and pain easing function and its formulation |
| 06/29/2005 | CN1631407A Dispersible tablet for activating blood and easing pain and its preparation process |
| 06/29/2005 | CN1631383A Medicinal wine having therapeutic functions for scapulohumeral periarthritis, arthritis and pains of arms and legs |
| 06/29/2005 | CN1631358A Compound pseudoephedrine hydrochloric acid containing powder for treating cold, its prescription and preparation method |
| 06/29/2005 | CN1208342C [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application |
| 06/29/2005 | CN1208336C Tert-butyl-(7-methyl-imidazo [1, 2-a] pyridine-3-yl)-amine derivatives |
| 06/29/2005 | CN1208323C Alpha-substituted carboxylic acid derivatives |
| 06/29/2005 | CN1208087C Method and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 06/29/2005 | CN1208082C Yunan red drug tablet , its preparation method and use |
| 06/29/2005 | CN1208074C Externally used Chinese medicinal preparation for treating gynaecology disease of cervicitis |
| 06/29/2005 | CN1208072C Capsule for treating rheumatism, osteoporosis and hyperosteogeny disease and preparation method thereof |
| 06/29/2005 | CN1208059C Medication comprising lornoxicam and niacinamide |
| 06/29/2005 | CN1208056C Medicine containing Anemonin as effective component for treating aseptic inflammation |
| 06/28/2005 | US6911543 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 06/28/2005 | US6911542 Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives |
| 06/28/2005 | US6911465 For treating inflammatory diseases including rheumatoid arthritis, glomerular nephritides, lung fibrosis, restenosis, alveolitis, asthma, psoriasis, inflammatory bowel disease, multiple sclerosis and brain trauma, stroke, ischemia |
| 06/28/2005 | US6911458 Compounds |
| 06/28/2005 | US6911451 Phenylalanine derivatives |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 06/28/2005 | US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911426 Inhibitor of apoptosis proteins (IAP); survivin |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/23/2005 | WO2005056527A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 06/23/2005 | WO2005056044A1 Use of c-reactive protein to treat immune complex-mediated renal disease |
| 06/23/2005 | WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 06/23/2005 | WO2005014584A9 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 06/23/2005 | WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases |
| 06/23/2005 | WO2003056896A3 Use of cytokines secreted by dendritic cells |
| 06/23/2005 | US20050137414 New aminopropylphosphinic acids |
| 06/23/2005 | US20050137263 e.g., 2-[(4-Ethyl-2-fluorophenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)benzamide, is administered to treat arthritis |
| 06/23/2005 | US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic |
| 06/23/2005 | US20050137239 Thiazole derivatives |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137229 Novel compounds |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137214 Inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137202 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors |
| 06/23/2005 | US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | CA2549401A1 Heterocyclic anti-migraine agents |
| 06/23/2005 | CA2548922A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders |
| 06/23/2005 | CA2548602A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 06/23/2005 | CA2547631A1 Methods for treating inflammation using thyroid stimulating hormone |
| 06/23/2005 | CA2547410A1 1,2,3-triazole amide derivatives as inhibitors of cytokie production |
| 06/23/2005 | CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544281A1 Fat composition |
| 06/22/2005 | EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 06/22/2005 | EP1543834A1 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/22/2005 | EP1543824A2 Thiazole derivatives to counter advanced glycation |
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543013A1 Novel compound |
| 06/22/2005 | EP1543009A1 Pyrrolotriazine kinase inhibitors |
| 06/22/2005 | EP1542984A2 Methods of purifying cannabinoids from plant material |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |
| 06/22/2005 | EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 06/22/2005 | EP1542976A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1542974A1 Novel compound |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids |
| 06/22/2005 | EP1542728A1 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 06/22/2005 | EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 06/22/2005 | EP1542695A1 Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. |
| 06/22/2005 | EP1542694A1 New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542657A1 Cannabinoid liquid formulations for mucosal amdinistration |
| 06/22/2005 | EP1542528A1 A method of treatment and prophylaxis |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1272200B1 Divided dose therapies with vascular damaging activity |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1233964B1 New use and novel n-azabicyclo-amide derivatives |
| 06/22/2005 | EP1173201B1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | EP1040111B1 Integrin receptor antagonists |
| 06/22/2005 | CN1630730A Methods for detecting and treating the early onset of aging-related conditions |
| 06/22/2005 | CN1630716A Hematopoietic cells from human embryonic stem cells |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630638A Aryl ureas as kinase inhibitors |
| 06/22/2005 | CN1630637A Novel arylheteroalkylamine derivatives |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630535A Inhibition of STAT-1 |
| 06/22/2005 | CN1630521A Oral compositions and methods for prevention, reduction and treatment of radiation injury |
| 06/22/2005 | CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1630512A Pharmaceutical tablet |
| 06/22/2005 | CN1629182A Oslasodine hydrochloride preparing process |
| 06/22/2005 | CN1629157A Piperazinyl triazine compounds, preparation method thereof and pharmaceutical composition containing same |
| 06/22/2005 | CN1628834A Freeze dried powder injection of Bupleurum root and its preparation process |